ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,163Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 3001

$1.46M Total Retail Price of All Prescriptions

Rank: 37 out of 3001

541 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 541 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 541 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 18,409 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

48 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LEVOTHYROXINE SODIUM 928 709 1 3
LISINOPRIL 882 550 2 2
FUROSEMIDE 828 588 3 6
OMEPRAZOLE 700 487 4 4
METFORMIN HCL 594 312 5 9
SIMVASTATIN 577 455 6 1
POTASSIUM CHLORIDE 554 346 7 15
HYDROCODONE-ACETAMINOPHEN 524 330 S3 8 7
AMLODIPINE BESYLATE 477 442 9 5
GABAPENTIN 471 328 10 14
METOPROLOL TARTRATE 418 353 11 8
HYDROCHLOROTHIAZIDE 321 208 12 10
CLOPIDOGREL 316 231 13 28
TRAMADOL HCL 311 218 14 17
LOVASTATIN 282 216 15 38
DONEPEZIL HCL 276 224 16 27
RANITIDINE HCL 268 185 17 41
WARFARIN SODIUM 267 242 18 12
ATENOLOL 257 174 19 18
NEXIUM 256 178 20 23
CARVEDILOL 251 189 21 25
FLUTICASONE PROPIONATE 247 167 22 42
PROAIR HFA 246 150 23 30
SERTRALINE HCL 241 158 24 20
CITALOPRAM HBR 240 200 25 16
PLAVIX 221 163 26 46
ISOSORBIDE MONONITRATE ER 217 157 27 45
ATORVASTATIN CALCIUM 213 144 28 11
FAMOTIDINE 211 110 29 68
GLIMEPIRIDE 206 144 30 31
PRAVASTATIN SODIUM 204 139 31 13
JANUVIA 199 137 32 54
CRESTOR 182 129 33 33
NAMENDA 177 177 34 40
TRIAMTERENE-HCTZ 162 62 35 48
ZETIA 162 119 35 69
METOPROLOL SUCCINATE 160 110 37 19
DIGOXIN 160 125 37 65
SINGULAIR 159 111 39 95
TRIAMTERENE-HYDROCHLOROTHIAZID 157 124 40 203
SPIRONOLACTONE 152 88 41 75
ACTOS 152 113 41 113
TAMSULOSIN HCL 148 111 43 29
ZOLPIDEM TARTRATE 145 102 44 24
PANTOPRAZOLE SODIUM 143 116 45 43
MELOXICAM 143 112 45 34
POLYETHYLENE GLYCOL 3350 142 97 47 55
TIZANIDINE HCL 141 49 48 101
LISINOPRIL-HYDROCHLOROTHIAZIDE 135 60 49 22
OXYBUTYNIN CHLORIDE ER 135 91 49 79
DILTIAZEM ER 134 134 51 256
DEXILANT 131 95 52 257
BUPROPION XL 128 81 53 176
IBUPROFEN 125 72 54 74
KLOR-CON M20 125 103 54 52
ENALAPRIL MALEATE 124 123 56 83
TRAZODONE HCL 124 92 56 37
ALENDRONATE SODIUM 123 119 58 26
LANTUS SOLOSTAR 123 57 58 80
CELEBREX 122 122 60 89
FENOFIBRATE 121 94 61 59
SUCRALFATE 118 75 62 164
LANSOPRAZOLE 118 45 62 140
NOVOLOG 115 95 64 94
CYMBALTA 113 47 65 53
LOSARTAN POTASSIUM 112 83 66 21
ROPINIROLE HCL 109 98 67 88
MIRTAZAPINE 106 96 68 44
HYDRALAZINE HCL 106 97 68 104
ALLOPURINOL 105 86 70 35
LANTUS 104 87 71 47
TERAZOSIN HCL 104 74 71 135
OXYCODONE-ACETAMINOPHEN 102 76 S2 73 32
PHENYTOIN SODIUM EXTENDED 101 64 74 126
LIDODERM 101 53 74 122
NAPROXEN 101 81 74 84
BUSPIRONE HCL 92 14 77 91
DILTIAZEM 24HR ER 92 62 77 131
PAROXETINE HCL 89 53 79 60
DILTIAZEM 24HR CD 86 78 80 124
LYRICA 85 55 81 87
CYCLOBENZAPRINE HCL 85 26 R 81 73
AMITRIPTYLINE HCL 85 22 R 81 85
BYSTOLIC 84 40 84 137
KLOR-CON M10 84 59 84 138
PROPRANOLOL HCL 83 0 86 136
CLONIDINE HCL 82 58 87 64
DIOVAN 80 77 88 50
AMLODIPINE BESYLATE-BENAZEPRIL 79 74 89 78
CIPROFLOXACIN HCL 77 52 90 56
ESCITALOPRAM OXALATE 77 52 90 82
TRICOR 77 42 90 132
OXYBUTYNIN CHLORIDE 76 37 93 120
PEN NEEDLE 73 36 94 128
MONTELUKAST SODIUM 73 51 94 175
PROMETHAZINE HCL 72 50 R 96 93
ETODOLAC 72 40 96 187
SOTALOL 71 42 98 266
SYNTHROID 69 51 99 71
VENLAFAXINE HCL ER 68 61 100 103
AZITHROMYCIN 68 42 100 36
SPIRIVA 67 54 102 57
INSULIN SYRINGE 66 57 103 162
TRILIPIX 66 42 103 193
RISPERIDONE 66 52 103 63
NOVOLOG FLEXPEN 64 24 106 169
GLIPIZIDE 64 63 106 67
DIVALPROEX SODIUM ER 63 31 108 142
COMBIVENT 62 22 109 184
MECLIZINE HCL 61 59 110 153
TOPIRAMATE 61 0 110 156
LIPITOR 60 46 112 100
PREDNISONE 59 37 113 39
PIOGLITAZONE HCL 59 43 R 113 274
CEPHALEXIN 58 36 115 86
GLYBURIDE 58 53 R 115 62
HYDROXYZINE HCL 56 53 R 117 172
ADVAIR DISKUS 55 47 118 58
SODIUM CHLORIDE 54 41 119 199
LOSARTAN-HYDROCHLOROTHIAZIDE 54 38 119 49
NIASPAN 54 41 119 133
BENZTROPINE MESYLATE 53 23 R 122 127
LEVEMIR FLEXPEN 52 36 123 188
BUPROPION HCL SR 52 50 123 190
BENICAR 52 38 123 206
DETROL LA 51 28 126 233
FLUOXETINE HCL 51 30 126 61
DOXAZOSIN MESYLATE 51 30 126 90
METOCLOPRAMIDE HCL 50 49 129 139
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 25, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.